Quarterly report pursuant to Section 13 or 15(d)

Debt and Interest - Additional Information (Detail)

v2.4.0.8
Debt and Interest - Additional Information (Detail) (USD $)
3 Months Ended 9 Months Ended 87 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Dec. 31, 2012
Sep. 30, 2013
Hercules Note [Member]
Sep. 30, 2013
Hercules Note [Member]
Oct. 31, 2013
Hercules Note [Member]
Subsequent Event [Member]
Sep. 30, 2013
Ovamed Manufacturing Rights [Member]
Sep. 30, 2013
Ovamed Manufacturing Rights [Member]
Dec. 31, 2012
Ovamed Manufacturing Rights [Member]
Installment
Debt Instrument [Line Items]                        
Accretion of obligation $ 493,000 $ 183,000 $ 1,454,000 $ 220,000 $ 5,407,000   $ 493,000 $ 1,453,000   $ 34,500 $ 100,500  
Term loan with Hercules Technology Growth Capital             15,000,000 15,000,000        
Cash interest paid             355,000 1,052,000        
Interest expenses accretion of debt discounts             99,000 286,000        
Current portion of note payable 6,062,000   6,062,000   6,062,000 1,799,000 6,100,000 6,100,000        
Non current portion of notes payable 8,408,000   8,408,000   8,408,000 12,386,000 8,900,000 8,900,000        
Debt discount recorded             530,000 530,000        
First principal payment made                 446,000      
Payment to acquire manufacturing rights                       1,500,000
Number of manufacturing rights installments                       3
Installment for manufacturing rights                       500,000
Acquired intangible assets payment initiation date                       2014-12
Acquired intangible assets payment expiration date                       2016-12
Net present value of long term liabilities                       1,000,000
Interest rate on net present value                       12.33%
Carrying amount obligation                       $ 1,500,000